Highlander Capital Management’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $56 | Hold |
4
| – | – | ﹤0.01% | 926 |
|
|
2023
Q4 | $26 | Hold |
4
| – | – | ﹤0.01% | 969 |
|
|
2023
Q3 | $0 | Buy |
+4
| New | – | ﹤0.01% | 922 |
|
|
2023
Q2 | – | Sell |
-4
| Closed | – | – | 683 |
|
|
2023
Q1 | $0 | Hold |
4
| – | – | ﹤0.01% | 668 |
|
|
2022
Q4 | $0 | Hold |
4
| – | – | ﹤0.01% | 634 |
|
|
2022
Q3 | $0 | Hold |
4
| – | – | ﹤0.01% | 627 |
|
|
2022
Q2 | $0 | Hold |
4
| – | – | ﹤0.01% | 637 |
|
|
2022
Q1 | $0 | Hold |
4
| – | – | ﹤0.01% | 618 |
|
|
2021
Q4 | $0 | Hold |
4
| – | – | ﹤0.01% | 601 |
|
|
2021
Q3 | $0 | Hold |
4
| – | – | ﹤0.01% | 601 |
|
|
2021
Q2 | $0 | Hold |
4
| – | – | ﹤0.01% | 614 |
|
|
2021
Q1 | $0 | Hold |
4
| – | – | ﹤0.01% | 624 |
|
|
2020
Q4 | $0 | Hold |
4
| – | – | ﹤0.01% | 615 |
|
|
2020
Q3 | $1K | Hold |
4
| – | – | ﹤0.01% | 579 |
|
|
2020
Q2 | $1K | Hold |
4
| – | – | ﹤0.01% | 575 |
|
|
2020
Q1 | $0 | Buy |
+4
| New | – | ﹤0.01% | 640 |
|